Gmt Capital Corp Amylyx Pharmaceuticals, Inc. Transaction History

Gmt Capital Corp

  • $2.45 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024
BUY
$12.07 - $18.46 $2.53 Million - $3.87 Million
209,700 Added 36.39%
786,000 $11.6 Million
Q3 2023

Nov 13, 2023
BUY
$18.08 - $23.45 $2.08 Million - $2.7 Million
115,300 Added 25.01%
576,300 $10.6 Million
Q2 2023

Aug 10, 2023
BUY
$20.98 - $31.42 $9.67 Million - $14.5 Million
461,000 New
461,000 $9.94 Million

Others Institutions Holding AMLX

# of Institutions
127
Shares Held
44M
Call Options Held
235K
Put Options Held
530K
View Full List

About Amylyx Pharmaceuticals, Inc.

AMLX Quotes by TradingView
  • Ticker AMLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,533,200
  • Market Cap $211M
  • Description
  • Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...
More about AMLX
Track This Portfolio

Track Gmt Capital Corp Portfolio

Follow Gmt Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gmt Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Gmt Capital Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email